α-Synuclein Misfolding and Neurodegenerative Diseases

被引:163
作者
Uversky, Vladimir N. [1 ,2 ,3 ]
机构
[1] Indiana Univ, Inst Intrinsically Disordered Prot Res, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat,Sch Med, Indianapolis, IN 46202 USA
[2] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia
[3] Mol Kinet Inc, Indianapolis, IN 46268 USA
基金
美国国家卫生研究院;
关键词
alpha-Synuclein; synucleinopathies; aggregation; fibril; nerodegeneration; natively unfolded protein;
D O I
10.2174/138920308785915218
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein is an abundant presynaptic brain protein, misfolding, aggregation and fibrillation of which are implicated as critical factors in several neurodegenerative diseases. The list of the well-known synucleinopathies includes such devastating disorders as Parkinson's disease, Lewy body variant of Alzheimer's disease, diffuse Lewy body disease, dementia with Lewy bodies, multiple system atrophy, and neurodegeneration with brain iron accumulation type I. The precise functions of alpha-synuclein remain elusive, but there are evidence indicating its involvement in regulation vesicular release and/or turnover and synaptic function in the central nervous system. It might play a role in neuronal plasticity responses, bind fatty acids, regulate certain enzymes, transporters, and neurotransmitter vesicles, be involved in neuronal survival and even can act as a molecular chaperone. Structurally, alpha-synuclein is an illustrative member of the rapidly growing family of natively unfolded (or intrinsically disordered) proteins and considerable knowledge has been accumulated about its structural properties and conformational behavior. The molecular mechanisms underlying misfolding, aggregation and fibrillation of alpha-synuclein and the role of various environmental and genetic factors in stimulation and inhibition of these processes are relatively well understood. Here, the main structural features of alpha-synuclein, its functions, and involvement in various human diseases are summarized providing a foundation for better understanding of the biochemistry, biophysics and neuropathology of alpha-synuclein aggregation.
引用
收藏
页码:507 / 540
页数:34
相关论文
共 519 条
[1]   Risk of dementia in Parkinson's disease - A community-based, prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Nielsen, H ;
Kragh-Sorensen, P .
NEUROLOGY, 2001, 56 (06) :730-736
[2]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[3]   Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[4]  
ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901
[5]   Mass spectrometry in proteomics [J].
Aebersold, R ;
Goodlett, DR .
CHEMICAL REVIEWS, 2001, 101 (02) :269-295
[6]   A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells [J].
Ahn, BH ;
Rhim, H ;
Kim, SY ;
Sung, YM ;
Lee, MY ;
Choi, JY ;
Wolozin, B ;
Chang, JS ;
Lee, YH ;
Kwon, TK ;
Chung, KC ;
Yoon, SH ;
Hahn, SJ ;
Kim, MS ;
Jo, YH ;
Min, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12334-12342
[7]   14-3-3 PROTEINS ON THE MAP [J].
AITKEN, A .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (03) :95-97
[8]   14-3-3-PROTEINS - BIOLOGICAL FUNCTION AND DOMAIN-STRUCTURE [J].
AITKEN, A ;
JONES, D ;
SONEJI, Y ;
HOWELL, S .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (03) :605-611
[9]   Tubulin seeds α-synuclein fibril formation [J].
Alim, MA ;
Hossain, MS ;
Arima, K ;
Takeda, K ;
Izumiyama, Y ;
Nakamura, M ;
Kaji, H ;
Shinoda, T ;
Hisanaga, S ;
Uéda, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :2112-2117
[10]   Aluminum-containing antacids as a cause of idiopathic Parkinson's disease [J].
Altschuler, E .
MEDICAL HYPOTHESES, 1999, 53 (01) :22-23